Additionally, research findings indicate that the Klotho operates as an antifibrotic in kidney diseases which are mainly linked with the decreased amounts of early growth response 1 (Egr-1) expression through the blocking of TGF-β1/ suppressor of mother against decapentaplegic (SMAD) signaling in HG exposed human mesangial cells [93]. This evidence concerns the gene KL and kidney disorder.